Daniel Arthur Caños, PhD, MPH, is the Director of the Office of Clinical Evidence and Analysis (OCEA) in the FDA Center for Devices and Radiological Health (CDRH).  Prior to joining OCEA in 2019, Daniel was the Director of the Evidence Development Division (EDD) in the Centers for Medicare and Medicaid Services (CMS) Coverage and Analysis Group (CAG) and was on a part time detail within the FDA CDRH. The EDD work included National Coverage Analyses (NCAs) and National Coverage Determinations (NCDs) involving Coverage with Evidence Development and review of FDA approved Investigational Device Exemption studies for CMS coverage determination. Before joining CAG in 2016, Daniel was an Associate Director in the FDA CDRH Division of Epidemiology. He originally joined FDA in 2008. He received a BA in Psychology from the University of Cincinnati, MPH from the George Washington University, and PhD in Epidemiology from the University of North Carolina at Chapel Hill. 

Conflict of Interest Disclosures:  No Conflicts